ChristophHeuckMD

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Heuck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
111 E 210th St
Hoffheimer Building 2nd Fl.
Bronx, NY 10467
Phone+1 718-920-4826

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
Humboldt University of Berlin - Charite Faculty of MedicineClass of 2003

PubMed

38 citations
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma
Jeffrey R. Sawyer, Erming Tian, Christoph Heuck, Donald J. Johann, Joshua Epstein
Blood. 2014-12-06
156 citations
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
Niels Weinhold, Cody Ashby, Leo Rasche, Shweta S. Chavan, Caleb K. Stein
Blood. 2016-09-29
7 citations
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Ola Landgren, Thomas J Prior, Tara Masterson, Christoph Heuck, Orlando F Bueno
Blood. 2024-07-25

$New Analyses Demonstrate Versatility and Continued Efficacy of TALVEYtm in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma$
New Analyses Demonstrate Versatility and Continued Efficacy of TALVEYtm in the Treatment of Patients with Relapsed or Refractory Multiple MyelomaDecember 16th, 2023